Helixate NexGen
In the US, Helixate NexGen is a member of the drug class miscellaneous coagulation modifiers and is used to treat Hemophilia A.
UK matches:
- Helixate NexGen 1000 IU
- Helixate NexGen 2000 IU
- Helixate NexGen 250 IU
- Helixate NexGen 500 IU
- Helixate NexGen (SPC)
Ingredient matches for Helixate NexGen
Coagulation Factor VIII , Human (rDNA) Octocog Alfa (a derivative of Coagulation Factor VIII , Human (rDNA)) is reported as an ingredient of Helixate NexGen in the following countries:
- France
- Norway
- Spain
- Sweden
- United Kingdom
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| SPC | Summary of Product Characteristics (UK) |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
